Neuralink's Patient Registry is now open globally

Yesterday at 07:34 AM

Neuralink opened its patient registry to people globally, broadening access to its brain-computer interface trials.

"The Neuralink Patient Registry is now open globally! If you have quadriplegia and are interested in exploring groundbreaking ways to control a computer using your thoughts, you can now sign up from anywhere in the world," the company announced in a recent X post.

Interested individuals can join by submitting their email through Neuralink's patient portal.

The tech firm currently runs two feasibility trials: the PRIME Study and the CONVOY Study. While Neuralink didn't clarify which study the registry targets, accepted patients are likely to participate in the PRIME Study, which is focused on its Link brain-computer interface (BCI). The CONVOY Study explores brain-controlled assistive robotic devices.

In February, Neuralink shared details on PRIME Study participants—Conrad, Alex, and Brad—who showcased transformative experiences with Link. Alex, a PRIME participant, also enrolled as the inaugural participant in the CONVOY Study. Unlike PRIME's broad testing of Link, CONVOY zeroes in on controlling devices like an assistive robotic arm (ARA).

"ARA control expands autonomy beyond smart devices and could allow people with paralysis to perform tasks in daily life such as feeding themselves and handling physical objects," Neuralink explained.

The global registry rollout marks a milestone for Neuralink, amplifying its reach to those with quadriplegia. With PRIME and CONVOY advancing, the company edges closer to merging human cognition with technology, potentially reshaping assistive solutions.

The post Neuralink's Patient Registry is now open globally appeared first on TESLARATI.